l-carnitine 500 gnc 500mg GNC L-Carnitine 500 mg |

pp 520 Parvin R, Pande SV

Methods Eligibility criteria The PICOS strategy was defined as follows: P (participants) human subjects, I (interventions) oral LC treatment, C (comparisons) between supplementation and placebo, supplementation and control, or pre- and post- supplementation, O (outcomes) muscle variables, and S (study design) randomized controlled trials, non-randomized controlled trials, non-randomized non-controlled trials

Penile curvature, plaque size, pain and disease progression were assessed

This product FMCF-21917 is part of Category:

While we have highlighted several implications of the data, some limitations must be considered